Observational studyDiabetes, obesity & metabolism2025

Effectiveness and safety of iGlarLixi in people with type 2 diabetes not at target on basal insulin and oral antidiabetic therapy in a prospective observational trial.

Jochen Seufert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.